Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

GSK announced that the US Department of Health and Human Services has placed initial orders for A influenza vaccine antigen and the company's proprietary adjuvant system, AS03, to support its pandemic influenza preparation efforts. GSK manufactures both a traditional vaccine antigen, which will be made from the recently isolated A influenza strain, as well as an adjuvant system. An adjuvant system can be added to the antigen at time of administration.

Today in Marketing/Media/ROI...keeping you current

Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09

Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09

Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address